CLINICAL_TRIALS
trial_result
· 2018-01-11
Clinical Trial Update: Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer [Phase 2]
Summary
Phase 2 trial evaluating levonorgestrel to prevent ovarian cancer in high-risk patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gynecologic Oncology Group | Conditions: Ovarian Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2018-01-11